AnandRathi

Symbiotec Pharmalab Ltd Fundamental Analysis

Last Updated Date: 23 Oct 2026
₹1,164.00
-34.05 (-2.84%)

Symbiotec Pharmalab Ltd (Symbiotec Pharma) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹7,479 crore.

Symbiotec Pharmalab Ltd Overview

Market cap₹7,479 Crs
Volume31,882
Prev. Close₹1,198.05
Year range₹933.80 - ₹1,310.00
ISININE899I01028

Symbiotec Pharmalab Ltd Fundamentals

P/E Ratio (TTM)64.56
P/B Ratio5.96
EPS (TTM)24.26
Dividend Yield0.00%
Book Value195.23
Profit Margin18.39%
Operating Margin22.25%

Symbiotec Pharmalab Ltd Historical Performance

1 Month Return9.59%
6 Month Return-
3 Year Return-
3 Month Return-
1 Year Return-
5 Year Return-

Symbiotec Pharmalab Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research